Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06926036 · ClinicalTrials.gov registry record · NA
Micromanaging Human Sleep Physiology to Treat Sleep Apnea and Other Disorders
A NA study of Sleep Apnea Obstructive (OSA), sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06926036: Recruiting NA study of Sleep Apnea Obstructive (OSA), sponsored by Northwestern University.
NCT06926036 is a NA study of Sleep Apnea Obstructive (OSA) that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06926036, a NA study of Sleep Apnea Obstructive (OSA), is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine whether a combination of breathing training during wake and targeted reactivation of the training during sleep can induce breathing changes during sleep and subsequent cognitive benefits during wake. Participants with obstructive sleep apnea (who have not yet been treated for sleep apnea) will be recruited. Participants will engage in breath training for one week in their own homes and to record their sleep at home using commercially available mobile devices and subsequently have their sleep monitored for one night of polysomnography recordings plus targeted reactivation in a laboratory setting.
Primary Outcome
AHI indexes the severity of OSA on the night of the study.
Conditions Studied
Interventions
- BEHAVIORAL Wake training + TMR
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-04-03 |
| Est. Completion | 2027-04 |
| Phase | NA |
What NCT06926036 shows while recruiting
NCT06926036 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Sleep Apnea Obstructive (OSA) appearing as the primary indexed condition, and to 1 intervention - of which Wake training + TMR is the first listed.
NCT06926036 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06926036 about?
NCT06926036 is a clinical study titled "Micromanaging Human Sleep Physiology to Treat Sleep Apnea and Other Disorders". This study will examine whether a combination of breathing training during wake and targeted reactivation of the training during sleep can induce breathing changes during sleep and subsequent cognitive benefits during wake. Participants with obstructive sleep apnea (who have not yet been treated fo...
What is the current status of trial NCT06926036?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-04-03. Estimated completion is 2027-04.
What conditions does trial NCT06926036 study?
This clinical trial studies the following conditions: Sleep Apnea Obstructive (OSA).
What interventions are being tested in trial NCT06926036?
The interventions under investigation include: Wake training + TMR (BEHAVIORAL).
Who is sponsoring clinical trial NCT06926036?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06926036 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06926036's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI